FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1958308045> ?p ?o ?g. }

• W1958308045 endingPage "790" @default.
• W1958308045 startingPage "781" @default.
• W1958308045 abstract "Summary. Background: Inhibitor development is influenced by several factors and the type of factor VIII (FVIII) products may play a role. Objectives: In order to explore such a role, we designed a cohort study whose novelty resides in the classification of products not only according to the source of FVIII (plasmatic, pd, or recombinant, r) but also to their degree of purity (expressed as specific activity). Patients/Methods: Treatment data up to inhibitor development or 150 exposure days were collected in 377 patients with hemophilia A. Results: Inhibitors developed in 111 patients (29%; 96 high-responders, 25%). The cumulative incidence was progressively higher from patients treated with low/intermediate-purity pdFVIII compared with those treated with high-purity pd and rFVIII. The adjusted hazard ratio of inhibitor development was 4.9 with rFVIII and 2.0 with high-purity pdFVIII (95% CI, 2.9–8.3 and 1.1–4.0), taking as reference low/intermediate-purity pdFVIII. There was no difference in the frequency of inhibitor testing between treatment groups. Sensitivity analyses (in patients who never switched product type, previously untreated patients, those treated on-demand and those with high-risk F8 mutations) confirmed an increased inhibitor risk with rFVIII and high-purity pdFVIII. Conclusions: This study shows that the degree of purity of FVIII products influences inhibitor development independently from other risk factors, and emphasizes that differences exist within pdFVIII products." @default.
• W1958308045 created "2016-06-24" @default.
• W1958308045 creator A5008489950 @default.
• W1958308045 creator A5033399787 @default.
• W1958308045 creator A5035546452 @default.
• W1958308045 creator A5065489740 @default.
• W1958308045 creator A5067175961 @default.
• W1958308045 creator A5077555392 @default.
• W1958308045 date "2012-05-01" @default.
• W1958308045 modified "2023-09-30" @default.
• W1958308045 title "Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A" @default.
• W1958308045 cites W1497860539 @default.
• W1958308045 cites W1525469616 @default.
• W1958308045 cites W1594468537 @default.
• W1958308045 cites W1903245222 @default.
• W1958308045 cites W1974712886 @default.
• W1958308045 cites W1976345010 @default.
• W1958308045 cites W1991223023 @default.
• W1958308045 cites W1992829986 @default.
• W1958308045 cites W2007128472 @default.
• W1958308045 cites W2008256582 @default.
• W1958308045 cites W2011753037 @default.
• W1958308045 cites W2019111170 @default.
• W1958308045 cites W2022748242 @default.
• W1958308045 cites W2026112167 @default.
• W1958308045 cites W2026272909 @default.
• W1958308045 cites W2037201482 @default.
• W1958308045 cites W2051456804 @default.
• W1958308045 cites W2052180704 @default.
• W1958308045 cites W2067687662 @default.
• W1958308045 cites W2075426161 @default.
• W1958308045 cites W2076831113 @default.
• W1958308045 cites W2081432681 @default.
• W1958308045 cites W2082183347 @default.
• W1958308045 cites W2106536550 @default.
• W1958308045 cites W2108014527 @default.
• W1958308045 cites W2116168381 @default.
• W1958308045 cites W2128487729 @default.
• W1958308045 cites W2130429639 @default.
• W1958308045 cites W2147887043 @default.
• W1958308045 cites W2149564822 @default.
• W1958308045 cites W2152384688 @default.
• W1958308045 cites W2154252930 @default.
• W1958308045 cites W2163023662 @default.
• W1958308045 cites W2275737843 @default.
• W1958308045 cites W2474454397 @default.
• W1958308045 cites W2789426532 @default.
• W1958308045 cites W98859 @default.
• W1958308045 doi "https://doi.org/10.1111/j.1538-7836.2012.04691.x" @default.
• W1958308045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22452823" @default.
• W1958308045 hasPublicationYear "2012" @default.
• W1958308045 type Work @default.
• W1958308045 sameAs 1958308045 @default.
• W1958308045 citedByCount "49" @default.
• W1958308045 countsByYear W19583080452012 @default.
• W1958308045 countsByYear W19583080452013 @default.
• W1958308045 countsByYear W19583080452014 @default.
• W1958308045 countsByYear W19583080452015 @default.
• W1958308045 countsByYear W19583080452016 @default.
• W1958308045 countsByYear W19583080452017 @default.
• W1958308045 countsByYear W19583080452018 @default.
• W1958308045 countsByYear W19583080452019 @default.
• W1958308045 countsByYear W19583080452020 @default.
• W1958308045 countsByYear W19583080452021 @default.
• W1958308045 countsByYear W19583080452022 @default.
• W1958308045 countsByYear W19583080452023 @default.
• W1958308045 crossrefType "journal-article" @default.
• W1958308045 hasAuthorship W1958308045A5008489950 @default.
• W1958308045 hasAuthorship W1958308045A5033399787 @default.
• W1958308045 hasAuthorship W1958308045A5035546452 @default.
• W1958308045 hasAuthorship W1958308045A5065489740 @default.
• W1958308045 hasAuthorship W1958308045A5067175961 @default.
• W1958308045 hasAuthorship W1958308045A5077555392 @default.
• W1958308045 hasBestOaLocation W19583080451 @default.
• W1958308045 hasConcept C126322002 @default.
• W1958308045 hasConcept C207103383 @default.
• W1958308045 hasConcept C2524010 @default.
• W1958308045 hasConcept C33923547 @default.
• W1958308045 hasConcept C44249647 @default.
• W1958308045 hasConcept C61511704 @default.
• W1958308045 hasConcept C71924100 @default.
• W1958308045 hasConcept C90924648 @default.
• W1958308045 hasConceptScore W1958308045C126322002 @default.
• W1958308045 hasConceptScore W1958308045C207103383 @default.
• W1958308045 hasConceptScore W1958308045C2524010 @default.
• W1958308045 hasConceptScore W1958308045C33923547 @default.
• W1958308045 hasConceptScore W1958308045C44249647 @default.
• W1958308045 hasConceptScore W1958308045C61511704 @default.
• W1958308045 hasConceptScore W1958308045C71924100 @default.
• W1958308045 hasConceptScore W1958308045C90924648 @default.
• W1958308045 hasIssue "5" @default.
• W1958308045 hasLocation W19583080451 @default.
• W1958308045 hasLocation W19583080452 @default.
• W1958308045 hasOpenAccess W1958308045 @default.
• W1958308045 hasPrimaryLocation W19583080451 @default.
• W1958308045 hasRelatedWork W1580426574 @default.
• W1958308045 hasRelatedWork W1984877488 @default.
• W1958308045 hasRelatedWork W2089620537 @default.

• next